FORM FORMFACTOR INC
Semiconductors & Related Devices · Nasdaq · SEC CIK 1039399 · Fiscal year ends 12/26
Financial factors as of 2026-09-26 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY29.1%
TTM net income YoY325.1%
TTM EPS YoY311.3%
Revenue 3-yr CAGR14.0%
Net income 3-yr CAGR—
Margins
Gross margin47.1%
Operating margin18.3%
Net margin17.7%
FCF margin18.5%
EBITDA margin22.0%
Returns
ROE15.9%
ROA13.2%
ROIC (approx.)15.9%
Asset turnover0.74x
Leverage & solvency
Liabilities / assets17.5%
Debt / equity0.01x
Current ratio3.68x
Interest coverage—
Cash quality & payout
Operating cash flow / net income1.48x
Accruals ratio-6.3%
Payout ratio—
Capex / revenue7.7%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-27 | FY20242024-12-28 |
|---|---|---|
| Income statement | ||
| Revenue | $784.99M | $763.60M |
| Cost of revenue | $476.14M | $455.68M |
| Gross profit | $308.85M | $307.92M |
| R&D expense | $115.68M | $121.94M |
| SG&A expense | $133.07M | $141.79M |
| Operating income | $57.07M | $64.78M |
| Interest expense | $521,000 | $418,000 |
| Pretax income | $69.39M | $79.41M |
| Income tax | $13.00M | $9.80M |
| Net income | $54.36M | $69.61M |
| EBITDA | $94.66M | $97.68M |
| EPS (basic) | 0.70 | 0.90 |
| EPS (diluted) | 0.69 | 0.89 |
| Weighted avg. shares (diluted) | 78.31M | 78.44M |
| Balance sheet | ||
| Cash & equivalents | $103.33M | $197.21M |
| Short-term investments | $171.84M | $169.29M |
| Receivables | $125.42M | $104.29M |
| Inventory | $110.88M | $101.68M |
| Current assets | $557.05M | $605.13M |
| PP&E, net | $259.07M | $210.23M |
| Goodwill | $216.03M | $199.17M |
| Intangibles | $16.30M | $10.36M |
| Total assets | $1.22B | $1.15B |
| Current liabilities | $123.86M | $131.34M |
| Short-term debt | $1.14M | $1.11M |
| Long-term debt | $11.07M | $12.21M |
| Total debt | $12.21M | $13.31M |
| Total liabilities | $188.96M | $198.45M |
| Shareholders' equity | $1.04B | $947.77M |
| Net debt | -$91.12M | -$183.89M |
| Shares outstanding | 77.65M | 77.11M |
| Cash flow statement | ||
| Operating cash flow | $115.40M | $117.53M |
| Capital expenditure | $103.66M | $38.44M |
| Free cash flow | $11.74M | $79.10M |
| Investing cash flow | -$191.47M | -$33.48M |
| Financing cash flow | -$13.63M | -$64.61M |
| Depreciation & amortization | $37.59M | $32.90M |
| Stock-based compensation | $38.58M | $39.76M |
| Share buybacks | $26.24M | $53.30M |
Free plan shows the latest 2 periods; Pro shows all 17 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.